Results 101 to 110 of about 654,931 (251)

Sleeve lobectomy for an arteriovenous malformation in the bronchus intermedius in a child

Journal of Pediatric Surgery Case Reports, 2019
Arteriovenous malformations within the tracheobronchial tree in pediatric patients uncommonly present as hemoptysis, and can usually be treated with percutaneous transcatheter embolization.
Aditya Sengupta, Othman Aljohani, Howaida El-Said, Aparna Rao, Matthew Brigger, Raghav Murthy   +5 more
doaj   +1 more source

Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations. [PDF]

Int J Mol Sci
Pulmonary arteriovenous malformations (PAVMs) are vascular anomalies resulting in abnormal connections between pulmonary arteries and veins. In 80% of cases, PAVMs are present from birth, but clinical manifestations are rarely seen in childhood.
Lorente-Herraiz L, Cuesta AM, Recio-Poveda L, Botella LM, Albiñana V.   +4 more
europepmc   +2 more sources

A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome

Clinical Genetics, Volume 110, Issue 2, Page 139-149, August 2026.
We propose a phenotype‐based diagnostic framework for short telomere syndrome that integrates age‐adjusted telomere length, phenotypic manifestations, and genetic findings, where available. The framework is intended to guide clinical evaluation, longitudinal surveillance, and individualized management while acknowledging limitations in current telomere
Andrew Courtwright, Richard A. King, Jennie Vagher, Cate T. Levy, Juan Gallegos F. Orozco, Luis FZ Batista, Afaf Osman, Srinivas Tantavahi, Mary Beth Scholand   +8 more
wiley   +1 more source

Alk1 Signaling in Vascular Development [PDF]

, 2013
Heterozygous loss of the endothelial-specific transforming growth factor-beta (TGF-β) Type 1 receptor, activin receptor-like kinase 1 (ALK1), results in the autosomal dominant disorder, hereditary hemorrhagic telangiectasia type 2 (HHT2), which is ...
Laux, Derek William
core  

Interventional treatment of pulmonary arteriovenous malformations

, 2010
Pulmonary arteriovenous malformations (PAVM) are congenital vascular communications in the lungs. They act as right to left shunts so that the blood running through these malformations is not oxygenated or filtered.
Poul Erik Andersen, Kjeldsen, Anette Drøhse; id_orcid, Andersen, Poul Erik   +2 more
core   +1 more source

[Percutaneous transluminal embolization of pulmonary arteriovenous malformations]

, 2001
The aim was to evaluate the effect of embolisation of pulmonary arteriovenous malformations (PAVM), as estimated by contrast echocardiography, arterial blood-gas analyses and functional level, and further to evaluate procedure-related and late ...
Kjeldsen, A D; id_orcid, Andersen, P E, Oxhøj, H, Vase, P   +3 more
core   +1 more source

Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports

BMC Neurology, 2011
Background Paradoxical embolism due to pulmonary arteriovenous malformations is the main mechanism of brain infarction in patients with hereditary hemorrhagic telangiectasia.
Viader Fausto, Babin Emmanuel, Cogez Julien, Ribeiro Espartaco, Defer Gilles   +4 more
doaj   +1 more source

Pulmonary arteriovenous malformations: diagnostic and treatment characteristics

Jornal Brasileiro de Pneumologia, 2019
Objective: To present a case series of pulmonary arteriovenous malformations (PAVMs), describing the main clinical findings, the number/location of pulmonary vascular abnormalities, the clinical complications, and the treatment administered.
Willian Salibe-Filho, B. Piloto, E. D. de Oliveira, M. Castro, B. Affonso, J. M. da Motta-Leal-Filho, Edgar Bortolini, M. Terra-Filho   +7 more
semanticscholar   +1 more source

RAS Inhibitor RMC‐7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells

Journal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT RAS mutations occur in patients with several types of vascular anomalies, but effective treatments remain limited. To address this need, we evaluated the RAS (ON) multi‐selective inhibitor RMC‐7977 in human endothelial cells (ECs) expressing the NRASQ61R mutation found in kaposiform lymphangiomatosis (KLA).
Sara Alharbi, Svatava Merkle, Patricia Pastura, C. Griffin McDaniel, George S. Zaky, Andrew M. Waters, Timothy D. Le Cras   +6 more
wiley   +1 more source

Oral Clues to Osler Disease

Journal of General and Family Medicine, Volume 27, Issue 5, September 2026.
Mika Watanabe, Yuki Otsuka, Yuya Yokota, Fumio Otsuka   +3 more
wiley   +1 more source